Abstract
Background: Modern lifestyle changes and the interlinking of non-communicable diseases result in the development of chronic kidney disease (CKD). While research has focused on attenuating the CKD, the role of mTOR in the progression of CKD is still unclear. Objectives: The current investigation was undertaken to study the role of mTOR-mediated signaling in CKD using Wistar male rats and adenine-induced CKD as an experimental model. Method: The animals were divided into 3 groups, representing control, CKD, and rapamycin-pretreated rats. At the end of the experimental period, blood biochemical indexes on kidney function and expression levels of fibrotic markers, including TGF-β, PAI-1, α-smooth muscle action, fibronectin, CTGF, and collagen-1, were analyzed. In addition, kidney injury markers such as kim-1, cystatin-C, NAG, and NGAL, indicating a progressive fibrotic response, were also studied. Results: The results suggest that mTOR inhibition significantly attenuated the induction of fibrosis, with restored serum creatinine and blood urea nitrogen levels. Intriguingly, the microRNA (miRNA) analysis revealed an increased expression of miR-193–5p, miR-221, miR-212, and miR-183–5p in CKD, while an increased mRNA expression of anti-inflammatory cytokines and reduced level of pS6K with attenuated miRNA was found in rapamycin-treated rats compared to the CKD animals. Conclusion: Activation of mTOR is the major responsive element with activation of miRNAs as an elementary role in the progression of kidney disease. Hence, targeting mTOR would be a possible strategy of treatment for CKD.
References
1.
Viau
A
, El Karoui
K
, Laouari
D
, Burtin
M
, Nguyen
C
, Mori
K
, et al Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
. J Clin Invest
. 2010
Nov
;120
(11
):4065
–76
.
[PubMed]
0021-97382.
Khan
Z
, Pandey
M
. Role of kidney biomarkers of chronic kidney disease: an update
. Saudi J Biol Sci
. 2014
Sep
;21
(4
):294
–9
.
[PubMed]
1319-562X3.
Rysz
J
, Gluba-Brzózka
A
, Franczyk
B
, Jabłonowski
Z
, Ciałkowska-Rysz
A
. Novel Biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome
. Int J Mol Sci
. 2017
Aug
;18
(8
):E1702
.
[PubMed]
1661-65964.
Hu
HH
, Chen
DQ
, Wang
YN
, Feng
YL
, Cao
G
, Vaziri
ND
, et al New insights into TGF-β/Smad signaling in tissue fibrosis
. Chem Biol Interact
. 2018
Aug
;292
:76
–83
.
[PubMed]
0009-27975.
Yu
J
, Yu
C
, Feng
B
, Zhan
X
, Luo
N
, Yu
X
, et al Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs
. BMC Nephrol
. 2019
Aug
;20
(1
):336
.
[PubMed]
1471-23696.
Quaggin
SE
, Kreidberg
JA
. Development of the renal glomerulus: good neighbors and good fences
. Development
. 2008
Feb
;135
(4
):609
–20
.
[PubMed]
1011-63707.
Wasung
ME
, Chawla
LS
, Madero
M
. Biomarkers of renal function, which and when?
Clin Chim Acta
. 2015
Jan
;438
:350
–7
.
[PubMed]
0009-89818.
Khurana
R
, Ranches
G
, Schafferer
S
, Lukasser
M
, Rudnicki
M
, Mayer
G
, et al Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease
. RNA
. 2017
Feb
;23
(2
):142
–52
.
[PubMed]
1355-83829.
Liu
Y
. Cellular and molecular mechanisms of renal fibrosis
. Nat Rev Nephrol
. 2011
Oct
;7
(12
):684
–96
.
[PubMed]
1759-506110.
Mayer
G
. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease
. Nephrol Dial Transplant
. 2011
Apr
;26
(4
):1132
–7
.
[PubMed]
0931-050911.
Bushati
N
, Cohen
SM
. microRNA functions
. Annu Rev Cell Dev Biol
. 2007
;23
(1
):175
–205
.
[PubMed]
1081-070612.
13.
Yokozawa
T
, Zheng
PD
, Oura
H
. Biochemical features induced by adenine feeding in rats. Polyuria, electrolyte disorders, and 2,8-dihydroxyadenine deposits
. J Nutr Sci Vitaminol (Tokyo)
. 1984
Jun
;30
(3
):245
–54
.
[PubMed]
0301-480014.
Yokozawa
T
, Oura
H
, Koizumi
F
. 2,8-Dihydroxyadenine urolithiasis induced by dietary adenine in rats
. Nihon Jinzo Gakkai Shi
. 1985
Mar
;27
(3
):371
–8
.
[PubMed]
0385-238515.
Diwan
V
, Brown
L
, Gobe
GC
. Adenine-induced chronic kidney disease in rats
. Nephrology (Carlton)
. 2018
Jan
;23
(1
):5
–11
.
[PubMed]
1320-535816.
Yang
H
, Song
Y
, Liang
YN
, Li
R
. Quercetin treatment improves renal function and protects the kidney in a rat model of adenine-induced chronic kidney disease
. Med Sci Monit
. 2018
Jul
;24
:4760
–6
.
[PubMed]
1234-101017.
Matsuyama
Y
, Terawaki
H
, Terada
T
, Era
S
. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease
. Clin Exp Nephrol
. 2009
Aug
;13
(4
):308
–15
.
[PubMed]
1342-175118.
Goligorsky
MS
, Brodsky
SV
, Noiri
E
. Nitric oxide in acute renal failure: NOS versus NOS
. Kidney Int
. 2002
Mar
;61
(3
):855
–61
.
[PubMed]
0085-253819.
Thompson
NL
, Flanders
KC
, Smith
JM
, Ellingsworth
LR
, Roberts
AB
, Sporn
MB
. Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice
. J Cell Biol
. 1989
Feb
;108
(2
):661
–9
.
[PubMed]
0021-952520.
Schnaper
HW
, Jandeska
S
, Runyan
CE
, Hubchak
SC
, Basu
RK
, Curley
JF
, et al TGF-beta signal transduction in chronic kidney disease
. Front Biosci
. 2009
Jan
;14
(14
):2448
–65
.
[PubMed]
1093-994621.
Lloberas
N
, Cruzado
JM
, Franquesa
M
, Herrero-Fresneda
I
, Torras
J
, Alperovich
G
, et al Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats
. J Am Soc Nephrol
. 2006
May
;17
(5
):1395
–404
.
[PubMed]
1046-667322.
Wang
W
, Chan
YH
, Lee
W
, Chan
L
. Effect of rapamycin and FK506 on mesangial cell proliferation
. Transplant Proc
. 2001
Feb-Mar
;33
(1-2
):1036
–7
.
[PubMed]
0041-134523.
Mozes
MM
, Böttinger
EP
, Jacot
TA
, Kopp
JB
. Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice
. J Am Soc Nephrol
. 1999
Feb
;10
(2
):271
–80
.
[PubMed]
1046-667324.
Runyan
CE
, Schnaper
HW
, Poncelet
AC
. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1
. J Biol Chem
. 2004
Jan
;279
(4
):2632
–9
.
[PubMed]
0021-925825.
Choudhury
GG
. A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation
. J Biol Chem
. 2004
Jun
;279
(26
):27399
–409
.
[PubMed]
0021-925826.
MacKay
K
, Striker
LJ
, Stauffer
JW
, Doi
T
, Agodoa
LY
, Striker
GE
. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells
. J Clin Invest
. 1989
Apr
;83
(4
):1160
–7
.
[PubMed]
0021-973827.
Suzuki
S
, Ebihara
I
, Tomino
Y
, Koide
H
. Transcriptional activation of matrix genes by transforming growth factor beta 1 in mesangial cells
. Exp Nephrol
. 1993
Jul-Aug
;1
(4
):229
–37
.
[PubMed]
1018-778228.
Loeffler
I
, Wolf
G
. Transforming growth factor-β and the progression of renal disease
. Nephrol Dial Transplant
. 2014
Feb
;29
Suppl 1
:i37
–45
.
[PubMed]
0931-050929.
Zeisberg
EM
, Potenta
SE
, Sugimoto
H
, Zeisberg
M
, Kalluri
R
. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition
. J Am Soc Nephrol
. 2008
Dec
;19
(12
):2282
–7
.
[PubMed]
1046-667330.
Li
J
, Qu
X
, Bertram
JF
. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice
. Am J Pathol
. 2009
Oct
;175
(4
):1380
–8
.
[PubMed]
0002-944031.
Humphreys
BD
, Xu
F
, Sabbisetti
V
, Grgic
I
, Movahedi Naini
S
, Wang
N
, et al Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis
. J Clin Invest
. 2013
Sep
;123
(9
):4023
–35
.
[PubMed]
0021-973832.
Kuncio
GS
, Neilson
EG
, Haverty
T
. Mechanisms of tubulointerstitial fibrosis
. Kidney Int
. 1991
Mar
;39
(3
):550
–6
.
[PubMed]
0085-253833.
Hijmans
RS
, Rasmussen
DG
, Yazdani
S
, Navis
G
, van Goor
H
, Karsdal
MA
, et al Urinary collagen degradation products as early markers of progressive renal fibrosis
. J Transl Med
. 2017
Mar
;15
(1
):63
.
[PubMed]
1479-587634.
Eberhardt
W
, Plüss
C
, Hummel
R
, Pfeilschifter
J
. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells
. J Immunol
. 1998
May
;160
(10
):4961
–9
.
[PubMed]
0022-176735.
Beck
KF
, Eberhardt
W
, Walpen
S
, Apel
M
, Pfeilschifter
J
. Potentiation of nitric oxide synthase expression by superoxide in interleukin 1 beta-stimulated rat mesangial cells
. FEBS Lett
. 1998
Sep
;435
(1
):35
–8
.
[PubMed]
0014-579336.
Ratliff
BB
, Abdulmahdi
W
, Pawar
R
, Wolin
MS
. Oxidant Mechanisms in Renal Injury and Disease
. Antioxid Redox Signal
. 2016
Jul
;25
(3
):119
–46
.
[PubMed]
1523-086437.
Zhang
Y
, Huang
B
, Wang
HY
, Chang
A
, Zheng
XF
. Zheng XFS Emerging role of microRNAs in mTOR signaling
. Cell Mol Life Sci
. 2017
Jul
;74
(14
):2613
–25
.
[PubMed]
1420-682X38.
Fang
Y
, Yu
X
, Liu
Y
, Kriegel
AJ
, Heng
Y
, Xu
X
, et al miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation
. Am J Physiol Renal Physiol
. 2013
May
;304
(10
):F1274
–82
.
[PubMed]
1931-857X39.
Qin
W
, Chung
AC
, Huang
XR
, Meng
XM
, Hui
DS
, Yu
CM
, et al TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29
. J Am Soc Nephrol
. 2011
Aug
;22
(8
):1462
–74
.
[PubMed]
1046-667340.
Taïbi
F
, Metzinger-Le Meuth
V
, M’Baya-Moutoula
E
, Djelouat
M
, Louvet
L
, Bugnicourt
JM
, et al Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease
. Biochim Biophys Acta
. 2014
Jan
;1842
(1
):88
–98
.
[PubMed]
0006-300241.
Wanet
A
, Tacheny
A
, Arnould
T
, Renard
P
. miR-212/132 expression and functions: within and beyond the neuronal compartment
. Nucleic Acids Res
. 2012
Jun
;40
(11
):4742
–53
.
[PubMed]
0305-104842.
Ucar
A
, Vafaizadeh
V
, Jarry
H
, Fiedler
J
, Klemmt
PA
, Thum
T
, et al miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development
. Nat Genet
. 2010
Dec
;42
(12
):1101
–8
.
[PubMed]
1061-403643.
Yin
W
, Naini
SM
, Chen
G
, Hentschel
DM
, Humphreys
BD
, Bonventre
JV
. Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model
. J Am Soc Nephrol
. 2016
Jul
;27
(7
):1943
–57
.
[PubMed]
1046-6673© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
